Skip to content
V-Biognostics
Toggle menu
  • About
  • Contact
  • Products
    • Osteocalcin (1-49) Human (Synthetic)
    • Antibiotics
      • Amphotericin B (Fungizone)
      • Bestatin (Ubenimex)
      • Bleomycin Sulfate
      • Brefeldin A
      • Daptomycin
      • G418, Sulfate
      • Mitomycin C
      • Thiostrepton
      • Valinomycin
    • Protease Inhibitors 1
      • AEBSF
      • Alafosfalin (Synthetic)
      • ALLN (Calpain Inh. I)
      • ALLM (Calpain Inh. II)
      • Amastatin, HCl
      • Antipain, 2HCl
      • Bestatin, HCl
      • Calpain Inh. III
      • Calpeptin
    • Protease Inhibitors 2
      • E-64 (Synthetic)
      • E-64d
      • Elastase Inh. I
      • Leupeptin, HCl
      • Leupeptin, Hemisulfate
      • MG-132
      • Pepstatin A
      • Phosphoramidon
      • RG108
      • TLCK, HCl
  • GERBU
    • GERBU Esterquat Product List
    • GERBU Adjuvant Product List
    • GERBU Adjuvant Introduction
    • GERBU Adjuvants Product Manuals
  • Articles
  • Email Logo

Category: News

July 5, 2018News

I-MAK’s Distorted View of the U.S. Patent System

BIOtech Now Tom DiLenge In an opinion piece published at CNBC.com, Tahir Amin — co-founder of I-MAK — blames the U.S. patent […]

July 2, 2018News

Co-Pay Accumulator Programs Are a Bad Deal for Patients

BIOtech Now Andrew Segerman As we see time and time again, health insurance providers and pharmacy benefit managers (PBMs) are beginning to […]

June 29, 2018News

House Passes SUPPORT for Patients and Communities Act to Combat America’s Opioid Crisis

BIOtech Now Andrew Segerman Opioid abuse and addiction in America has reached epidemic heights. As a nation, we’re spending more than $500 […]

June 27, 2018News

New Report Offers “Distorted View” of Biopharma Industry

BIOtech Now Brian Newell This week, the Minority Staff of the U.S. Senate Committee on Finance released a report entitled, “A Tangled […]

June 21, 2018News

Insurers Shift Costs and Facts

BIOtech Now Andrew Segerman As health insurance companies begin setting rates for 2019, many consumers are once again faced with skyrocketing premium […]

June 18, 2018News

Future Leaders in Biotechnology

BIOtech Now Andrew Segerman BIO’s International Convention was packed with compelling keynote speeches, and dozens of fireside chats and breakout sessions featuring […]

June 7, 2018News

Heralding In A New Era of Precision Medicine

BIOtech Now Jeremy Isenberg The healthcare ecosystem is experiencing an acceleration in the uptake of the precision medicine paradigm due to many […]

June 6, 2018News

Ending the Opioid Epidemic Through Innovation

BIOtech Now Brian Newell Every day the opioid epidemic is destroying lives and communities across the country. Dr. Jeremy Levin, chairman and […]

June 5, 2018News

Robin Roberts Shares the Journey

BIOtech Now Athena Staton When Good Morning America co-anchor Robin Roberts was diagnosed with cancer in 2007, she took her mother’s advice […]

June 1, 2018News

NORD and the Orphan Drug Act Celebrate 35 Years Driving Rare Disease Advocacy, Research, and Innovation

BIOtech Now BIOtechNOW Editor The National Organization for Rare Disorders (NORD) has been instrumental in influencing public policy, regulatory frameworks, research, and […]

May 25, 2018News

Newborn Screening – How to Fill the Gap to End Diagnostic Odysseys

BIOtech Now BIOtechNOW Editor Many of the over 7000 rare diseases identified so far are not obvious at birth or may come […]

May 23, 2018News

On the President’s Drug Cost Plan, Three Important Concerns

BIOtech Now Dan Durham Part 1. Restricting access under Medicare Part D  The Trump administration is out with its plan to lower […]

May 7, 2018News

Drug Importation and Its Dangerous Side Effects

BIOtech Now Andrew Segerman Writing for the National Review, Sally Pipes of the Pacific Research Institute authors a stark warning about the […]

May 3, 2018News

BIO Communications Responds to Misleading Op-Ed about Medicaid Drug Costs

BIOtech Now Andrew Segerman This week, Dr. Peter Bach of Memorial Sloan-Kettering Cancer Center authored an op-ed about the cost of prescription […]

May 2, 2018News

Dr. Jeremy Levin on BIO’s Path to an Addiction-Free America

BIOtech Now Andrew Segerman This week, Dr. Jeremy Levin, Chairman and CEO of Ovid Therapeutics and Chair of BIO’s Opioid Working Group […]

May 1, 2018News

ICYMI: Access to Medication-Assisted Treatment Critical in Fighting Opioid Addiction

BIOtech Now Andrew Segerman Opioid abuse and addiction in America has reached epidemic heights. The Centers for Disease Control and Prevention reports […]

April 30, 2018News

60 Minutes Shines Spotlight on the Power and Promise of CRISPR

BIOtech Now Andrew Segerman On Sunday night, 60 Minutes ran a captivating segment on the promise and possibilities of CRISPR – the […]

April 25, 2018News

Vaccines: Vital in fighting antimicrobial resistance

BIOtech Now BIOtechNOW Editor In recognition of BIO’s 25th Anniversary, each month we are celebrating historical milestones in biotech. This week marks […]

April 20, 2018News

The Latest Good News on Prescription Drug Costs

BIOtech Now Jim Greenwood Two-hundred biotech allies from more than 40 different states visited Washington D.C. this week. These advocates met with […]

April 10, 2018News

Fact Checking Misleading Claims about Drug Costs

BIOtech Now Andrew Segerman In a series of new blogs, AHIP once again paints drug manufacturers as the culprit for rising health […]

Posts navigation

< 1 … 35 36 37 … 47 >
Partnering with:   Quartett GERBU Adjuvants

V-BIOGNOSTICS, "Ingredients For Life" is a BioTech company devoted to research in life science reagents worldwide. We source difficult to find biochemicals for the advancement in research of antibody production, Immunohistochemistry, drug development, molecular biology, cell biology, cancer research, Immunotherapy, Oncology, drug discovery, and agricultural biotechnology. We work hard for speedy processing and delivery of your products and at very competitive pricing offering you a high quality alternative to big pharma for your sourcing and manufacturing needs.

D&B VERIFIED Seal

We Supply the highest quality protease inhibitors, antibiotics, and Adjuvants including: Bestatin HCl, Leupeptin Hemisulfate / Hydrochloride, AEBSF, G418, Elastatinal, E-64, Pepstatin, Calpain, Bleomycin Sulfate, Proteinase K, MG-132, ALLM, ALLN, Antipain, Anti-Human Rabbit IgG, GERBU Monoclonal/Polyclonal Adjuvant, synthetic and custom synthesis. Please Contact Us or visit our Products, About, or Terms pages for more information.

Biotech Articles

  • How can proteomic analysis improve our understanding of the ageing process. Find out in your latest issue of BioTechniques!
  • Mutated gene is the driver of psoriasis
  • The latest developments in microbiology from a diverse cast of characters
  • Scientists stymie sarcopenia
  • Decoding the neuroanatomical signature of developmental language disorder
  • Lac-Phe: the mechanism behind metformin’s role in weight loss
© 2025 V-Biognostics. Proudly powered by Sydney